Cargando…

Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.

Detalles Bibliográficos
Autores principales: Becher, R., Kloke, O., Höffken, K., Scheulen, M. E., Wandl, U. B., Bojar, H., Schmidt, C. G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246743/
https://www.ncbi.nlm.nih.gov/pubmed/2525403
_version_ 1782150832296296448
author Becher, R.
Kloke, O.
Höffken, K.
Scheulen, M. E.
Wandl, U. B.
Bojar, H.
Schmidt, C. G.
author_facet Becher, R.
Kloke, O.
Höffken, K.
Scheulen, M. E.
Wandl, U. B.
Bojar, H.
Schmidt, C. G.
author_sort Becher, R.
collection PubMed
description
format Text
id pubmed-2246743
institution National Center for Biotechnology Information
language English
publishDate 1989
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-22467432009-09-10 Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma. Becher, R. Kloke, O. Höffken, K. Scheulen, M. E. Wandl, U. B. Bojar, H. Schmidt, C. G. Br J Cancer Research Article Nature Publishing Group 1989-06 /pmc/articles/PMC2246743/ /pubmed/2525403 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Becher, R.
Kloke, O.
Höffken, K.
Scheulen, M. E.
Wandl, U. B.
Bojar, H.
Schmidt, C. G.
Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
title Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
title_full Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
title_fullStr Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
title_full_unstemmed Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
title_short Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
title_sort phase ii study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246743/
https://www.ncbi.nlm.nih.gov/pubmed/2525403
work_keys_str_mv AT becherr phaseiistudyofhighdosemedroxyprogesteroneacetateinadvancedmalignantmelanoma
AT klokeo phaseiistudyofhighdosemedroxyprogesteroneacetateinadvancedmalignantmelanoma
AT haffkenk phaseiistudyofhighdosemedroxyprogesteroneacetateinadvancedmalignantmelanoma
AT scheulenme phaseiistudyofhighdosemedroxyprogesteroneacetateinadvancedmalignantmelanoma
AT wandlub phaseiistudyofhighdosemedroxyprogesteroneacetateinadvancedmalignantmelanoma
AT bojarh phaseiistudyofhighdosemedroxyprogesteroneacetateinadvancedmalignantmelanoma
AT schmidtcg phaseiistudyofhighdosemedroxyprogesteroneacetateinadvancedmalignantmelanoma